Juan F. Gallegos-Orozco, MD

Journal Article

1. Mohan BP, Iriana S, Khan SR, Yarra P, Ponnada S, Gallegos-Orozco JF (2022). Outcomes of liver transplantation in patients 70 years or older: a systematic review and meta-analysis. Ann Hepatol, 27(6), 100741. (Read full article)
2. Mohan BP, Iriana S, Khan SR, Yarra P, Ponnada S, Gallegos-Orozco JF (2022). Outcomes of liver transplantation in patients 70 years or older: a systematic review and meta-analysis. Annals of Hepatology.
3. Izzy M, Fortune BE, Serper M, Bhave N, deLemos A, Gallegos-Orozco JF, Guerrero-Miranda C, Hall S, Harinstein ME, Karas MG, Kriss M, Lim N, Palardy M, Sawinski D, Schonfeld E, Seetharam A, Sharma P, Tallaj J, Dadhania DM, VanWagoner LB (2022). Management of Cardiac Diseases in Liver Transplant Recipients: Comprehensive Review and Multidisciplinary Practice-Based Recommendations.  PMID: 35359027. American Journal of Transplant.
4. Wong YJ, Qiu TY, Tam YC, Mohan BP, Gallegos-Orozco JF, Adler DG (2020). Efficacy and Safety of IV albumin for non-spontaneous bacterial peritonitis infection among patients with cirrhosis: A systematic review and meta-analysis. Dig Liver Dis, 52(10), 1137-1142. (Read full article)
5. Bajaj JS, Brenner DM, Cai Q, Cash BD, Crowell M, DiBaise J, Gallegos-Orozco JF, Gardner TB, Gyawali CP, Ha C, Holtmann G, Jamil LH, Kaplan GG, Karsan HA, Kinoshita Y, Lebwohl B, Leontiadis GI, Lichtenstein GR, Longstreth GF, Muthusamy VR, Oxentenko AS, Pimentel M, Pisegna JR, Rubenstein JH, Russo MW, Saini SD, Samadder NJ, Shaukat A, Simren M, Stevens T, Valdovinos M, Vargas H, Spiegel B, Lacy BE (2020). Major Trends in Gastroenterology and Hepatology Between 2010 and 2019: An Overview of Advances From the Past Decade Selected by the Editorial Board of The American Journal of Gastroenterology. Am J Gastroenterol, 115(7), 1007-1018. (Read full article)
6. Rofaiel G, Martinez E, Pan G, Sossenheimer M, OHara R, Gallegos J, Box T, Pham T, Campsen J, Goodale M, Kim R (2019). Creation of a Robotically Assisted Terminal Jejunogastrostomy Is Safe and Effective in Regaining Antegrade Enteral Bile Duct Access After Live Donor Liver Transplant With Roux Limb. Transplant Direct, 5(8), e476. (Read full article)
7. Garcia-Tsao G, Fuchs M, Shiffman M, Borg BB, Pyrsopoulos N, Shetty K, Gallegos-Orozco JF, Reddy KR, Feyssa E, Chan JL, Yamashita M, Robinson JM, Spada AP, Hagerty DT, Bosch J (2018). Emricasan (IDN-6556) Lowers Portal Pressure in Patients With Compensated Cirrhosis and Severe Portal Hypertension. Hepatology, 69(2), 717-728. (Read full article)
8. Charlton M, Levitsky J, Aqel B, OGrady J, Hemibach J, Rinella M, Fung J, Ghabril M, Thomason R, Burra P, Little EC, Berenguer M, Shaked A, Trotter J, Roberts J, Rodriguez-Davalos M, Rela M, Pomfret E, Heyrend C, Gallegos-Orozco J, Saliba F (2018). International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients. Transplantation, 102(5), 727-743. (Read full article)
9. Gallegos-Orozco JF, Charlton MR (2017). Predictors of Cardiovascular Events After Liver Transplantation. Clin Liver Dis, 21(2), 367-379. (Read full article)
10. Samadder NJ, Smith KR, Wong J, Hanson H, Boucher K, Burt RW, Charlton M, Byrne KR, Gallegos-Orozco JF, Koptiuch C, Curtin K (2016). Familial Risk of Biliary Tract Cancers: A Population-Based Study in Utah. Dig Dis Sci, 61(12), 3627-3632. (Read full article)
11. Gallegos-Orozco JF, Kim R, Thiesset HF, Hatch J, Lynch K, Chaly T Jr, Shihab F, Ahmed F, Hall I, Campsen J (2016). Early Results of Pilot Study Using Hepatitis C Virus (HCV) Positive Kidneys to Transplant HCV Infected Patients with End-Stage Renal Disease Allowing for Successful Interferon-Free Direct Acting Antiviral Therapy after Transplantation. Cureus, 8(11), e890. (Read full article)
12. Gallegos-Orozco JF, Silva AC, Batheja MJ, Chang YH, Hansen KL, Lam-Himlin D, De Petris G, Aqel BA, Byrne TJ, Carey EJ, Douglas DD, Mulligan DC, Silva AM, Rakela J, Vargas HE (2015). Magnetic resonance elastography can discriminate normal vs. abnormal liver biopsy in candidates for live liver donation. Abdom Imaging, 40(4), 795-802. (Read full article)
13. Porres-Aguilar M, Gallegos-Orozco JF (2014). Hepatopulmonary syndrome: Is it time to redefine the MELD exception score for better organ allocation and outcomes? Ann Hepatol, 13(4), 468-70. (Read full article)
14. Murad MH, Fernndez-Balsells MM, Barwise A, Gallegos-Orozco JF, Paul A, Lane MA, Lampropulos JF, Natividad I, Perestelo-Prez L, Ponce de Len-Lovatn PG, Albuquerque FN, Carey J, Erwin PJ, Montori VM (2010). Outcomes of surgical treatment for nonfunctioning pituitary adenomas: a systematic review and meta-analysis. Clin Endocrinol (Oxf), 73(6), 777-91. (Read full article)
15. Gallegos-Orozco JF, Yosephy A, Noble B, Aqel BA, Byrne TJ, Carey EJ, Douglas DD, Mulligan D, Moss A, de Petris G, Williams JW, Rakela J, Vargas HE (2009). Natural history of post-liver transplantation hepatitis C: A review of factors that may influence its course. Liver Transpl, 15(12), 1872-81. (Read full article)

Review

1. Izzy M, Fortune BE, Serper M, Bhave N, deLemos A, Gallegos-Orozco JF, Guerrero-Miranda C, Hall S, Harinstein ME, Karas MG, Kriss M, Lim N, Palardy M, Sawinski D, Schonfeld E, Seetharam A, Sharma P, Tallaj J, Dadhania DM, VanWagner LB (2022). Management of cardiac diseases in liver transplant recipients: Comprehensive review and multidisciplinary practice-based recommendations. [Review]. Am J Transplant, 22(12), 2740-2758. (Read full article)
2. Izzy M, Fortune BE, Serper M, Bhave N, deLemos A, Gallegos-Orozco JF, Guerrero-Miranda C, Hall S, Harinstein ME, Karas MG, Kriss M, Lim N, Palardy M, Sawinski D, Schonfeld E, Seetharam A, Sharma P, Tallaj J, Dadhania DM, VanWagner LB (2022). Management of Cardiac Diseases in Liver Transplant Recipients: Comprehensive Review and Multidisciplinary Practice-Based Recommendations. [Review]. Am J Transplant, 22(12), 2740-2758. (Read full article)
3. Chandna S, Zarate ER, Gallegos-Orozco JF (2021). Management of Decompensated Cirrhosis and Associated Syndromes. [Review]. Surg Clin North Am, 102(1), 117-137. (Read full article)
4. Chandna S, Rodriguez Zarate E, Gallegos-Orozco JF (2021). Management of decompensated cirrhosis and associated syndromes. [Review]. Surg Clin North Am, 102, 117-137.
5. Gallegos-Orozco JF, Charlton M (2017). Predictors of cardiovascular events after liver transplantation. [Review]. Clin Liver Dis, 21(2), 367-379.
6. Gallegos-Orozco JF, Charlton MR (2016). Alcoholic Liver Disease and Liver Transplantation. [Review]. Clin Liver Dis, 20(3), 521-34. (Read full article)
7. Unzueta A, Gallegos-Orozco JF (2013). Noninvasive diagnosis of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Oncology Gastroenterology Hepatology Reports. [Review]. Oncology, 2, 8-16.
8. Porres-Aguilar M, Gallegos-Orozco JF, Garcia H, Aguirre J, Macias-Rodriguez RU, Torre-Delgadillo A (2013). Pulmonary vascular complications in portal hypertension and liver disease: a concise review. [Review]. Rev Gastroenterol Mex, 78(1), 35-44. (Read full article)
9. Gallegos-Orozco JF, Foxx-Orenstein AE, Sterler SM, Stoa JM (2012). Chronic constipation in the elderly. [Review]. Am J Gastroenterol, 107(1), 18-25; quiz 26. (Read full article)

Book Chapter

1. Gallegos-Orozco JF (2023). Hepatitis por inhibidores del punto de control inmunitario [Immune checkpoint inhibitor hepatitis]. In Yamamoto Furusho JK, Uscanga Dominguez LF (Eds.), Enfermedades del aparato digestivo inmunomediadas [Immune mediated diseases of the digestive system] (pp. 83-88). Mexico City, Mexico: Permanyer.
2. Aguilar MT, Chandna S, Gallegos-Orozco JF (2023). Primary Sclerosing Cholangitis. In Yamamoto Furusho JK, Uscanga Dominguez LF (Eds.), Enfermedades del aparato digestivo inmunomediadas [Immune mediated diseases of the digestive system] (pp. 95-102). Mexico City, Mexico: Permanyer.
3. Unzueta A, Gallegos-Orozco JF (2017). Factores de riesgo en tumores hepaticos [Risk factors for liver tumors]. In Chirino-Sprung RA, Torre-Delgadillo A (Eds.), XII Congreso Nacional de Hepatologia (First, pp. 121-125). Mexico City: Permanyer.
4. Unzueta Santos A, Gallegos-Orozco JF (2016). Fibrosis hepática: nuevas alternativas terapéuticas. [Liver fibrosis: new therapeutic options]. In Uscanga L (Ed.), 70 años de Gastroenterología en el Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán: Los Grandes Temas del Departamento (pp. 13-18). Mexico City, Mexico: Permanyer Mexico.
5. Garca Senz de Sicilia M, Gallegos-Orozco JF (2016). Tratamiento actual de la hepatitis crónica por virus de la hepatitis C [Current treatment of chronic hepatitis C]. In Uscanga L. (Ed.), 70 años de Gastroenterología en el Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán: Los Grandes Temas del Departamento (pp. 119-124). Mexico City, Mexico: Permanyer Mexico.
6. Doycheva I, Gallegos-Orozco JF (2016). Acute viral hepatitis: hepatitis A, hepatitis E and other viruses. In Talley NJ, DeVault KR, Wallace MB, Aqel B, Lindor KD (Eds.), Practical Gastroenterology and Hepatology Board Review Toolkit (2nd Edition, pp. 465-72). Oxford: Wiley-Blackwell.
7. Gallegos-Orozco JF (2015). Tratamiento actual del enfermo con hepatitis crónica por hepatitis C: un ejemplo de medicina traslacional [Current treatment of chronic hepatitis C: an example of translational medicine]. In Torre A, Uscanga-Domínguez LF (Eds.), Medicina individualizada: de la evidencia a la práctica clínica (pp. 43-49). Mexico City, Mexico: Permanyer Mexico.
8. Gallegos-Orozco JF, Campsen J (01/01/2015). Liver transplant-related malignancies. In Busuttil W, Klintmalm GB (Eds.), Transplantation of the Liver (3rd Edition, pp. 1191-1209). Saunders.
9. Pham T, Gallegos-Orozco JF (01/01/2014). New treatments for chronic hepatitis C. In Uscanga-Domínguez LF, Yamamoto-Furusho JK (Eds.), Gastroenterología Translacional. La investigación básica al servicio de la práctica clínica. Barcelona: Permanyer Publications.
10. Hatch J, Gallegos-Orozco JF (2013). Preoperative evaluation of patients with cirrhosis. In Gonzalez-Huezo MS, Sanchez-Avila JF (Eds.), Hepatología: de la ciencia básica a la aplicación clínica (pp. 107-12). Mexico City: ZarPra Ediciones.
11. Porres-Aguilar M, Gallegos-Orozco JF (2013). Pulmonary complications in liver cirrhosis. In Gonzalez-Huezo MS, Sanchez-Avila JF (Eds.), Hepatología: de la ciencia básica a la aplicación clínica (pp. 153-7). Mexico City: ZarPra Ediciones.
12. Unzueta A, Gallegos-Orozco JF (2012). Esteatohepatitis no alcohólica, ¿Cuál es el mejor método diagnóstico? In Torre-Delgadillo A, Kershenobich D (Eds.), Tópicos Innovadores en Hepatología (1st Edition, pp. 265-74). Mexico City: ZarPra Ediciones.
13. Costilla VC, Gallegos-Orozco JF (2012). Terapias biológicas en el hepatocarcinoma. In Torre-Delgadillo A, Kershenobich D (Eds.), Tópicos Innovadores en Hepatología (1st Edition, pp. 373-88). Mexico City: ZarPra Ediciones.
14. Gallegos-Orozco JF, Vargas HE (2012). Drug-Induced, Granulomatous, and Other Inflammatory Hepatic Diseases. In DiBaise J (Ed.), Gastroenterology and Hepatology Board Review: Pearls of Wisdom (3rd Edition, pp. 389-98). New York: McGraw-Hill Medical.

Case Report

1. Chaly T, Campsen J, OHara R, Hardman R, Gallegos-Orozco JF, Thiesset H, Kim RD (2017). Mucocele mimicking a gallbladder in a transplanted liver: A case report and review of the literature. World J Transplant, 7(6), 359-363. (Read full article)
2. Horner BJ, Craig R, Harris ES, Kovacsovics T, Gallegos-Orozco JF (2017). Acute liver failure secondary to AL amyloidosis. Clin Med Rev Case Rep, 4(2), 157.
3. Gallegos-Orozco JF, Gurudu SR, Orenstein R (2012). First successful colonoscopic fecal transplant for severe acute Clostridium difficile pseudomembranous colitis. Rev Gastroenterol Mex.
4. Werner KT, Gallegos-Orozco JF (2012). Multiple hepatic abscesses secondary to chicken bone penetration of the colon: a case report. Rev Gastroenterol Mex, 77(1), 43-6. (Read full article)
5. Gallegos-Orozco JF, Paskvan-Gawryletz CD, Gurudu SR, Orenstein R (2012). Successful colonoscopic fecal transplant for severe acute Clostridium difficile pseudomembranous colitis. Rev Gastroenterol Mex, 77(1), 40-2. (Read full article)

Editorial

1. Gallegos-Orozco JF (2019). The Growing Challenge of Advanced Liver Disease Due to Alcohol Use in the United States. Am J Gastroenterol, 114(11), 1712-1713. (Read full article)
2. Gallegos-Orozco JF, Charlton MR (2015). Treatment of HCV prior to liver transplantation to prevent HCV recurrence - wise or wasteful? Liver Int, 35(1), 9-11. (Read full article)

Abstract

1. Campsen J, Kim R, Thiesset H, Chaly T, Shihab F, Ahmed F, Gallegos-Orozco JF (2016). Expanding the donor pool using HCV+ kidneys to cure HCV and end-stage renal disease. [Abstract]. American Journal of Transplantation, 16(S1), 44-45.
2. Abduljawad B, Hatch J, Lynch KM, Stevens K, Thomason IR, Box TD, Gallegos-Orozco JF (2016). Real world experience with interferon-free direct acting antivirals in the treatment of patients with chronic hepatitis C. Accepted for presentation during DDW in San Diego, California, USA, May 2016. [Abstract]. Gastroenterology, 150(Supplement 1), S1104.
3. Parbhu SK, Haseeb A, Gallegos-Orozco JF (01/15/2015). Ursodeoxycholic acid (UDCA) therapy in acute cytomegalovirus (CMV) hepatitis associated cholestasis. Accepted for presentation at the 80th Annual Meeting of the American College of Gastroenteorlogy in Honolulu, Hawaii. [Abstract].
4. Haseeb A, Gallegos-Orozco JF (11/07/14). Hepatic encephalopathy, a preventable readmission: implementation of quality indicators at a tertiary care center. 65th Annual Meeting of the American Association for the Study of Liver Diseases in Boston, MA. [Abstract]. Hepatology, (Supp 60), 397A.
5. Unzueta A, Moreira RK, De Petris G, Smith ML, Chang Y-H H, Cheng M-R, Eyshou A, Gallegos-Orozco JF, Aqel B, Vargas HE (11/07/14). Validation of the hepatitis aggressiveness score in a liver transplant population with recurrent hepatitis C. 65th Annual Meeting of the American Association for the Study of Liver Diseases in Boston, MA. [Abstract]. hepatology, (Supp 60), 535A.
6. Chervenak AE, Bashar A, Byrne TJ, Carey EJ, Rakela J, Hartel LA, Gallegos-Orozco JF, Sapola AM, Vargas HE (2012). Treatment of HCV in the DAA era: the impact of a multidisciplinary team. Presented at the 63rd Annual Meeting of the American Association for the Study of Liver Diseases in Boston, MA. [Abstract]. Hepatology, 56(Suppl), 228A.
7. Gallegos-Orozco JF, Chervenak AE, Carey EJ, Bashar A, Byrne TJ, Hartel LA, Rakela J, Vargas HE (2012). Liver transplant center focused experience with peginterferon alfa-2ª, ribavirin and telaprevir therapy in patients with genotype 1 hepatitis C cirrhosis. Presented at the 63rd Annual Meeting of the American Association for the Study of Liver Diseases in Boston, MA, [Abstract]. Hepatology, 56(Suppl), 218A-219A.
8. Gallegos-Orozco JF, Silva AM, Chang Y-H, Batheja MJ, Hansen KL, Lam-Himlin D, De Petris G, Carey EJ, Aqel BA, Byrne TJ, Douglas DD, Mulligan DC, Silva A, Vargas HE (2012). Magnetic resonance elastography (MRE) can discriminate normal vs. abnormal liver biopsy in candidates for live liver donation. Young Investigator Award Winner. Presented at the International Liver Transplantation Society 17th Annual International Congress. San Francisco, CA. [Abstract]. Liver Transpl, 18(Suppl 1), S111.
9. Gallegos-Orozco JF, Silva AM, Chang Y-H, Batheja MJ, Hansen KL, Lam-Himlin D, De Petris G, Carey EJ, Aqel BA, Byrne TJ, Douglas DD, Mulligan DC, Rakela J, Silva A, Vargas HE (2012). Magnetic resonance elastography (MRE) can discriminate normal vs. abnormal liver biopsy in candidates for live liver donation. Presented at the International Liver Congress in Barcelona, Spain. [Abstract]. J Hepatol, (56), S96.

Podcasts

• How Sugar Converts to Fat
• Proper Diet Is Critical for Patients with Liver Disease
• Liver Dialysis Clinical Trials Begin at University of Utah
• Hidden Hepatitis

• ALPINE 4: Evaluation of Efficacy, Safety and Tolerability of NGM282 (Aldafermin) in a Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study in Subjects with Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
• Testing the Drug HM15211 for People with Nonalcoholic Steatohepatitis
• Mirum VISTAS
• Liver Transplantation in Patients with Cirrhosis and Severe Acute-on-Chronic Liver Failure (ACLF)
• Lanifibranor in adult patients with non-cirrhotic non-alcoholic steatohepatitis (NASH) and fibrosis 2 (F2)/fibrosis 3 (F3) stage of liver fibrosis
• Volixibat: A Possible Rare Liver Disease Medication
• Testing the Study Drug INT-787 for Adults with Severe Alcohol-Associated Hepatitis